396 research outputs found
Histopathology of ameloblastoma of the jaws; some critical observations based on a 40 years single institution experience
The aim of the present study is to examine all cases of intraosseous benign ameloblastomas treated between 1970 and 2010 in a single institution and to look for a possible correlation between the histopathological aspects and the demographical and clinical parameters, as well as the treatment outcome. The data of a total number of 44 patients were retrieved from the records. Nine patients were excluded because of doubt about the correct diagnosis (8 patients) or because of an extra-osseous presentation (1 patient). No statistically significant differences were found between the histopathological (sub)types of ameloblastomas and the demographical and clinical parameters, nor between the histopathological (sub)types and treatment outcome. Of the 28 patients treated by enucleation, in 17 patients one or more recurrences occurred, with no significant predilection for any histopathological (sub)type, including the unicystic type. There were no significant differences in the recurrence rate after enucleation in patients below and above the age of 20 years either. In six out of 17 patients with a recurrence, the recurrent lesion showed a different histopathological subtype than was encountered in the primary. In two cases a change from solid/multicystic to desmoplastic ameloblastomas was noticed. In conclusion, the current histopathological classification of benign intraosseous ameloblastoma does not seem to have clinical relevance with the possible exception of the luminal unicystic ameloblastoma that has been removed in toto, unfragmented. Since no primary desmoplastic ameloblastomas were encountered in the present study no further comments can be made on this apparently rare entity. © Medicina Oral S. L
Odontogenic keratocysts located in the buccal mucosa : a description of two cases and review of the literature
Odontogenic keratocysts make up 4%–12% of all odontogenic cysts. Most cysts are sporadic but sometimes they arise in the context of basal cell nevus syndrome (Gorlin syndrome). Most odontogenic keratocysts arise in the posterior region of the mandible, but they can occur anywhere in the jaw. In rare instances, they are located peripherally in the gingiva. Even more rare, they are found in the soft tissues of the mouth. There have been a few case reports and small case series of such peripheral odontogenic keratocysts. Some controversy exists as to whether these truly represent a peripheral counterpart of the intraosseous odontogenic keratocysts and if their origin is at all odontogenic. We hereby present two cases of peripheral odontogenic keratocysts, both being located in the soft tissue of the buccal mucosa, and review the literature on peripheral odontogenic keratocysts
Additional non-sentinel lymph node metastases in early oral cancer patients with positive sentinel lymph nodes
Non-classic EGFR mutations in a cohort of Dutch EGFR-mutated NSCLC patients and outcomes following EGFR-TKI treatment
The added value of SPECT-CT for the identification of sentinel lymph nodes in early stage oral cancer
The role of a labial salivary gland biopsy in the diagnostic procedure for Sjögren's syndrome: a study of 94 cases
Objectives: The purpose of the present study is to examine the role of the outcome of the labial salivary gland
biopsy (LSGB) in the diagnostic procedure of patients suspected of suffering from Sjögren's syndrome (SS).
Material
and Methods: In a retrospective study the result of histopathological assessment of 94 consecutively taken
labial salivary gland biopsies has been examined. For the diagnosis of SS the American-European Consensus
Group classification (AECG, 2002) have been used. The outcome of the assessment has been discussed in relation
to a recently reported classification provided by the American College of Rheumatology (ACR, 2012).
Results: In the 94 LSGBs support for a diagnosis of SS has been encountered in 24 out of 26 patients with SS. In
the 68 patients with a negative diagnosis of SS only six positive LSGBs were observed. The sensitivity of the labial
biopsy amounted 0.92; the specificity was 0.91, while the positive predictive value and the negative predictive
value amounted 0.80 and 0.97 respectively. LSGBs taken by or on the request of the departments of Rheumatology
or Internal Medicine had a significant higher yield compared to LSGBs taken in other clinical departments.
Conclusion
s
: The LSGB may play a role in the diagnostic procedure of Sjögren's syndrome when using either the
AECG classification or the ACR classification. A LSGB should preferably taken after counseling for the possible
presence of SS by a department of Rheumatology or Internal Medicine since the yield of such biopsies is much
higher than in patients who have not been counseled by these departments prior to the taking of a LSGB.
When using the ACR classification, a positive serologic result and a positive ocular test make the taking of a LSGB
redundant. Only in case of a negative serologic outcome or a negative result of the ocular test a LSGB is indicated.
Since both the serologic test and the ocular test carry hardly any morbidity, these tests should, indeed, be performed
first before considering to take a LSGB
Targeting PLK1 as a novel chemopreventive approach to eradicate preneoplastic mucosal changes in the head and neck
Clinicopathological characteristics and outcome of 31 patients with <em>ETV6-NTRK3</em> fusion gene confirmed (mammary analogue) secretory carcinoma of salivary glands
- …